Maharashtra, India , has emerged as a key hub for the production of Abacavir Sulfate API. Several pharmaceutical entities in the state are now actively engaged in the formulation of this essential antiretroviral substance. This rise is fueled by beneficial regulatory frameworks and a experienced workforce, positioning Maharashtra as a dependable… Read More


Abacavir sulfate is a nucleoside reverse transcriptase inhibitor utilized in the therapy of human immunodeficiency virus disease. Its pharmacological properties rely on the competitive inhibition of reverse transcriptase, an enzyme essential for HIV replication. Abacavir sulfate is a pro-drug that undergoes modification to its active for… Read More